Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives. Since our founding in 1909, our ever-growing mastery of plasma, diagnostics and life sciences, backed by our ethical leadership and industry-leading quality ...
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ...
Discover Grifols Canada, a leader in biopharmaceutical solutions dedicated to high-quality plasma therapies that enhance patient care and outcomes. Join us in improving health in your community.
The Globe and Mail: Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
Donors giving blood plasma at Grifols’ paid collection centres are not informed that some medicines made from their donations will be sold for profit overseas, according to testimony from a Canadian ...
Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
The Globe and Mail: Health Canada imposes new conditions on Grifols after deaths of two people who donated plasma
Health Canada is imposing new terms and conditions on the licences of Grifols, Canada’s only major commercial collector of blood plasma, after two people died following donations in recent months. The ...
Health Canada imposes new conditions on Grifols after deaths of two people who donated plasma
MarketWatch: Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance